Cardiovascular regenerative medicine is an emerging field focused on repairing and restoring damaged heart tissues using cutting-edge biological approaches. Stem cell therapy has shown promise in regenerating cardiomyocytes and improving heart function in patients with heart failure or myocardial infarction. Researchers are also exploring the potential of tissue engineering to create bioengineered heart patches for targeted repair. Additionally, advancements in gene editing techniques like CRISPR are being investigated to correct genetic mutations associated with cardiovascular disorders. By combining biomaterials, cellular therapies, and innovative delivery systems, cardiovascular regenerative medicine aims to revolutionize treatment outcomes and offer hope to patients suffering from severe cardiac conditions.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain